A genome-wide CRISPR screen maps endogenous regulators of PPARG gene expression in bladder cancer

Peroxisome proliferator-activated receptor gamma (PPARγ) is a nuclear receptor central in the regulation of key cellular processes including cell metabolism, tissue differentiation, and regulation of the immune system. PPARγ is required for normal differentiation of the urothelium and is thought to be an essential driver of the luminal subtype of bladder cancer. However, the molecular components that regulate PPARG gene expression in bladder cancer remain unclear. Here, we developed an endogenous PPARG reporter system in luminal bladder cancer cells and performed genome-wide CRISPR knockout screening to identify bona fide regulators of PPARG gene expression. Functional validation of the dataset confirmed GATA3, SPT6, and the cohesin complex components SMC1A, and RAD21, as permissive upstream positive regulators of PPARG gene expression in luminal bladder cancer. In summary, this work provides a resource and biological insights to aid our understanding of PPARG regulation in bladder cancer. [Display omitted] •An endogenous PPARG reporter system in luminal bladder cancer cells was developed•A genome-wide CRISPR knockout screen revealed putative regulators of PPARG gene expression•GATA3, SPT6, SMC1A, and RAD21 were validated as positive regulators of PPARG•This work provides a resource for insight into PPARG regulation in bladder cancer Biological sciences; Molecular biology; Molecular mechanism of gene regulation; Cancer